Pathos has officially dosed the first patient in its Phase 1b/2a clinical trial evaluating Pocenbrodib.

Mar 24

Written By Kimberly Hicks

Kimberly Hicks

Another strong quarter for our client Alnylam Pharmaceuticals

Congratulations to Alnylam Pharmaceuticals on the FDA Approval of Amvuttra.